Apricus Biosciences To Present At BIO-Europe Spring 2013

SAN DIEGO, March 7, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) ( www.apricusbio.com) announced today that Edward Cox, Vice President Corporate Development & Investor Relations, will present at the BIO-Europe Spring 2013 Partnering Conference, being held in Barcelona, Spain. Mr. Cox's presentation will take place on Wednesday, March 13, 2013 at 11:00 a.m. Local Time (6:00 a.m. Eastern Time).

A replay of the presentation will be accessible to the public online at the Company's website at http://www.apricusbio.com.

About Apricus Biosciences, Inc.

Apricus Biosciences, Inc. is a pharmaceutical company that develops and markets innovative treatments that help large patient populations across numerous, large-market therapeutic classes including male and female sexual health. The Company has one approved product, Vitaros®, for the treatment of erectile dysfunction, which will be marketed in Canada by Abbott Laboratories and Femprox®, a product candidate, for the treatment of female sexual arousal disorder, which successfully completed one 400-patient Phase III study in China.

For further information on Apricus Bio, visit http://www.apricusbio.com. You can also receive information at http://twitter.com/apricusbio.
CONTACT: Apricus Bio Investor Relations:         David Pitts         Argot Partners         212-600-1902         david@argotpartners.com

Apricus logo

More from Press Releases

NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling

NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling

21st Century Fox Scoops Up Local News Stations

21st Century Fox Scoops Up Local News Stations

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Three-Part FREE Webinar Series

Three-Part FREE Webinar Series

March 24 Full-Day Course Offering: Professional Approach to Trading SPX

March 24 Full-Day Course Offering: Professional Approach to Trading SPX